Referenzen für Dr.Maisch Reprosil Chiral HPLC-Säulen

siehe auch Chirapedia mit Substanzindex

ReproSil 100 Chiral-NR, 8 µm, 250 x 100 mm

Reprosil Chiral-NR

- Expression of fusion proteins of aspergillus terreus reveals a novel allene oxide synthase, I. Hoffmann, Journal of Biological Chemistry (2013) M113.458257. (Reprosil 100 Chiral-NR und -NRR, 8 µm;  Reprosil 100 Si, 5 µm, 250 x 10 mm)

 

- 3-amino-5-phenyl-56-dihydro-2h-[1,4]oxazines. M. Andreini, Patent, 2013, Nr. US 20130196984 A1. (Reprosil 100 Chiral-NR, 8 µm, 250 x 30 mm)

 

- Potent and selective, orally active GPBAR1 agonists as chemical biology probes. P. Mattei, Symposiumspräsentation, 2013.  (Reprosil Chiral-NR)

 

- Evolution of a designed retro-aldolase leads to complete active site remodeling, L. Giger, Nature Chemical Biology, 9 (2013) 494–498. (Reprosil 100 Chiral-NR, 8 µm, 250 x 20 mm)

 

- Transition metal complexes of axially chiral tetrathioether bay-substituted perylene bisimide dyes. M.J. Lin, Chemical Communications, 2013, DOI: 10.1039/C3CC45351K. Supplementary information. (Reprosil 100 Chiral-NR, 8 µm, 20 mm ID)

 

- Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects. J. Dingemanse, Drugs in R&D, 13 (2013) 145-151. (Reprosil 100 Chiral-NR, 8 µm, 125 x 3 mm)

 

 - Discovery of agonists of cannabinoid receptor 1 with restricted central nervous system penetration aimed for treatment of gastroesophageal reflux disease. A. T. Plowright, Journal of Medicinal Chemistry, 56 (2013)  220–240. (Reprosil 100 Chiral-NR, 8 μm, 250 x 20 mm)

 

- Synthesis of Tubuphenylalanines via Ireland–Claisen Rearrangement. D. Becker, Journal of Organic Chemistry, 78 (2013)  59–65. (Reprosil 100 Chiral-NR, 8 μm)

 

- Catalytic convergence of manganese and iron lipoxygenases by replacement of a single amino acid. A. Wennman, Journal of Biological Chemistry, 287 (2012) 31757-31765. Supplemental Data. (Reprosil 100 Chiral NR, 8 μm, 2 x 250 mm;  Reprosil Chiral-AM, 5 μm, 250 x 2 mm)

  

- Stereoselective oxidation of regioisomeric octadecenoic acids by fatty acid dioxygenases. E.H. Oliw, Journal of Lipid Research, 52 (2011) 1995-2004. (Reprosil 100 Chiral-NR und -NR-R, 8 μm, 250 x 4, 250 x 2 mm)

 

- Impact of Molecular Flexibility on Binding Strength and Self-Sorting of Chiral π-Surfaces. M.M. Safont-Sempere, Journal of American Cheical Society, 2011, 133 (24), pp 9580–9591. (Reprosil 100 Chiral-NR, 8 μm)

 

- Perylene bisimides with rigid 2,2′-biphenol bridges at bay area as conjugated chiral platforms. F. Würthner, Organic Letters, 12 (2010 3204–3207. (Reprosil 100 Chiral-NR)

  

- Enantioseparation of vesamicol and novel vesamicol analogs by high-performance liquid chromatography on different chiral stationary phases. B. Wenzel, 1217 (2010) 3855-62. (Reprosil 100 Chiral-NR, Chiral-OM, Chiral OM-RP, Chiral AM-RP, Chiral-AA)

 

- LC-MS/MS analysis of epoxyalcohols and epoxides of arachidonic acid and their oxygenation by recombinant CYP4F8 and CYP4F22. T. Nilsson, Archives of Biochemistry and Biophysics, 494 (2010) 64-71. (ReproSil 100 Chiral-NR, 8 µm, 250 x 4 mm;  Reprosil Chiral-AM, 5 µm, 250 x 2 mm)


- Heterocyclic compounds as against for the thyroid receptor. A.J. Lofstedt, Patent Nr. 20100004271 (2010). (ReproSil 100 Chiral-NR, 8 µm, 250 x 4.6 mm, 250 x 20 mm, 250 x 30 mm)

- Biochemical characterization of the oxygenation of unsaturated fatty acids by the dioxygenase and hydroperoxide isomerase of Pseudomonas aeruginosa 42A2, E. Martinez, The Journal of Biological Chemistry, 285 (2010) 9339-9345. (Reprosil 100 Chiral-NR und -NR-R)

- Recent trends in the advanced analysis of bioactive fatty acids. A. Ruiz-Rodriguez, Journal of Pharmaceutical and Biomedical Analysis, 51 (2010) 305-326. (Reprosil 100 Chiral-NR, 8 µm, 150 x 4.6 mm)

 

 - Diastereotopos-differentiating allylic alkylation as a key step in the synthesis of γ-glutamyl boletine. D. Gawas, Organic & Biomolecular Chemistry, 8 (2010) 457-462. (Reprosil 100 Chiral-NR, 8 µm)

 

- Perylene bisimides with rigid 2,2′-biphenol bridges at bay area as conjugated chiral platforms. F. Würthner, Organic Letters, 12 (2010) 3204–3207. (Reprosil 100 Chiral-NR, 8 μm)

 

- Heterocyclic compounds as against for the thyroid receptor. G. Collazo, US-Patent, 2010, No. 20100004271. (Reprosil 100 Chiral-NR, 8 µm, 250 x 20 mm, 250 x 4.6 mm)

 

- Chiral self-recognition and self-discrimination of strapped perylene bisimides by pi-stacking dimerization. M.M. Safont-Sempere, A European Journal, 16 (2010) 7380–7384. (Reprosil 100 Chiral-NR)

 

- Self-Assembling Porphyrins and Chlorins as Synthetic Mimics of the Chlorosomal Bacteriochlorophylls. T.S. Balaban, Handbook of Porphyrin Science, Vol.14, 2010, p.294. (Reprosil 100 Chiral-NR)  Zinc chlorins  n-Hexan/DCM 1:1

  

- A straightforward approach towards glycoamino acids and glycopeptides via Pd-catalysed allylic alkylation. K. Krämer, Organic Biomolecular Chemistry, 7 (2009) 103 -110 (Reprosil 100 Chiral-NR, 8 μm)  


- Linoleate 9R-dioxygenase and allene oxide synthase activities of Aspergillus terreus. F. Jernerén, Archives of Biochemistry and Biophysics, on-line, DOI: 10.1016/j.abb.2009.12.022v (Reprosil 100 Chiral-NR, 5 µm 250 x 2 mm;  Reprosil Chiral-AM, 5 µm 250 x 2 mm)
 

- Novel heterocyclic compounds. J.M. Adam, Patent, Nr. 20100022518 (2010). (Reprosil 100 Chiral-NR, 8 µm)


- Leucine/valine residues direct oxygenation of linoleic acid by (10
R)- and (8R)-dioxygenases. U. Garscha, Journal of Biological Chemistry, 284 (2009) 13755-13765. (Reprosil 100 Chiral-NR, 8 µm, 250 x 2 mm;  Reprosil Chiral-AM, 10 µm, 150 x 2 mm)

- alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases. K.M.Orrling, Bioorganic & Medical Chemistry, 17 (2009) 5933-5949. (Reprosil 100 Chiral-NRR, 8 µm, 250 x 4.6 mm, 250 x 20 mm)

- Synthesis and biological evaluation of pretubulysin and derivatives. A. Ulrich, European Journal of Organic Chemistry, 36 (2009) 6367-6378. (ReproSil 100 Chiral-NR, 8 µm)

- Mass spectrometric analysis of oxylipins. Application to cytochrome P450-dependent metabolism. T. Nilsson, Dissertation, Uppsala University, 2009. (
ReproSil 100 Chiral-NR und -NR-R, 8 µm, 250 x 4 mm)

-
Synthesis of chlamydocin by chelate-Claisen rearrangement. Ch. Quirin, European Journal of Organic Chemistry, 3 (2009) 371-377. (Reprosil 100 Chiral-NR, 8 µm, 250 x 4.6 mm)

- Synthese unnatürlicher Aminosäure-Derivate via Esterenolat-Claisen-Umlagerung und deren Anwendung in der Naturstoffsynthese. Ch. Quirin, Dissertation, Universität Saarbrücken, 2008. (Reprosil 100 Chiral-NR, 8 µm, 250 x 4.6 mm)


- High stereoselectivity in chelation-controlled intermolecular Heck reactions with aryl chlorides, vinyl chlorides and vinyl triflates. G.K. Datta,
Organic Biomolecular Chemistry, 21 (2008) 674-676. (ReproSil 100 Chiral-NR und -NR-R, 8 µm, 250 x 4.6 mm)

  , 19 (2008) 1120-1126. (
Reprosil 100 Chiral-NR und NR-R, 8 µm, 250 x 4.6 mm)
- Enantiomeric separation and analysis of unsaturated hydroperoxy fatty acids by chiral column chromatography-mass spectrometry. U. Garscha, Journal of Chromatography B, 872 (2008) 90-98. (ReproSil 100 Chiral-NR, 8 µm, 250 x 2 mm)
- Structure-property relationships for self-assembled zinc chlorin light-harvesting dye aggregates. V. Huber, Chemistry, 14 (2008) 7791-807. (ReproSil 100 Chiral-NR, 8 µm, 250 x 8 mm, 250 x 20 mm)

- Untersuchungen zur Synthese von Bottromycin B2, S. Ackermann, Dissertation, Universität Saarbrücken, 2008. (Reprosil 100 Chiral-NR, 8 um, 250 x 10 mm)

 

- Acidic ruthenium PNNP complexes of non-enolized 1,3-dicarbonyl compounds as catalysts for asymmetric Michael Addition. F. Santoro, Organometallics, 27 (2008) 3866–3878. (Reprosil 100 Chiral-NR, 8 μm)


- . S. Basak, European Journal of Organic Chemistry, 24 (2008) 4169-4177. (ReproSil 100 Chiral-NR, 8 µm)

- Ni(II)-catalyzed enantioselective Nazarov cyclizations. I. Walz, Chemical Communications, (2008) 4315-4317. (Reprosil 100 Chiral-NR, 8 µm, 250 x 20 mm)

- Katalytische Enantioselektive Nazarov-Cyclisierungen. I. Walz, Dissertation, ETH Zürich, 2007. (Reprosil 100 Chiral-NR, 8 µm 250 x 20 mm)


- Chelatisierte Peptid-Esterenolate in der Palladium-katalysierten allylischen Substitution. J. Deska, Dissertation, Universität Saarbrücken, 2007. (ReproSil 100 Chiral-NR, 8 µm, 250 x 4.6 mm)

- Stereoselektive Synthese und Umsetzung stannylierter Peptide. J. Deska, Angewandte Chemie, 119 (2007) 4654-4657. (
ReproSil 100 Chiral-NR, 8
µm)

-
. J. Deska, Chemistry A. European Journal, 13 (2007) 6204-6211. (ReproSil 100 Chiral-NR, 8
µm)

- Steric analysis of 8-hydroxy- and 10-hydroxyoctadecadienoicacids and dihydroxyoctadecadienoic acid formed from 8R-hydroperoxyoctadeca-dienoic acid by hydroxyperoxide isomerases.  U. Garscha,
Analytical Biochemistry, 367 (2007) 238-246. (ReproSil 100 Chiral NR, 8 µm, 250 x 2 mm)

- Identification of dioxygenases required for Aspergillus development. U. Garscha, The Journal of Biological Chemistry, 282  (2007) 34707-34718. (Reprosil 100 Chiral-NR, 8 µm)
- Effects of bay substituents on the racemization barriers of perylene bisimides: Resolution of atropo-enantiomers. P. Osswald, Journal of the American Chemical Society, 129 (2007) 14319-14326. (Reprosil 100 Chiral-NR, 8 µm, 250 x 4.6 mm, 250 x 20 mm)

- Perylene bisimide atropisomers: Synthesis, resolution, and stereochemical assignment
. P. Osswald, Journal of Organic Chemistry, 72 (2007) 3403-3411. (Reprosil 100 Chiral-NR, 8 µm, 250 x 4.6 mm, 250 x 20 mm)

- Perylene bisimide atropisomers: Synthesis and optical and chiroptical properties. P. Osswald, Dissertation, JMU Würzburg, 2007. (Reprosil 100 Chiral-NR, 8 µm, 250 x 4.6 mm, 250 x 20 mm)

- An optically active thyroid receptor antagonist and optically active key intermediates in its production. A.H. Sjoblom, Patent WO/2007/039125. (ReproSil 100 Chiral-NR, 8 µm, 250 x 20 mm)

- Preparation of novel unsymmetrical bisindoles under solvent-free conditions: synthesis, crystal structures, and mechanistic aspects. H.M. Kaiser,
Journal of Organic Chemistry,
72 (2007) 8847–8858. (ReproSil 100 Chiral-NR, 8 µm)
- Novel pharmaceutical compositions. A.M. Garcia Collazo, Patent WO/2007/128492. (ReproSil 100 Chiral NR, 8 µm, 250 x 20 mm)

- Effects of Bay Substituents on the Racemization Barriers of Perylene Bisimides: Resolution of Atropo-Enantiomers. P. Osswald, Journal of American Chemical Society, 129 (2007) 14319–14326. (Reprosil 100 Chiral-NR, 8 μm, 20 mm ID)

- Hoch stereoselective Palladium-katalysierte Allylierung von Peptiden. U. Kazmaier, Angewandte Chemie, 118 (2006) 4973-4976. (ReproSil 100 Chiral-NR, 8 µm, 250 x 20 mm)

- Chelatisierte Glycinesterenolate – Effiziente Nukleophile für Regio- und Stereoselektive Rhodium-katalysierte allylische Alkylierungen und Additionen an aromatische Nitrogruppen. D. Stolz, Dissertation, Universität Saarbrücken, 2006. (ReproSil 100 Chiral-NR, 8 µm, 250 x 4.6 mm)

Methods for treating CNS disorders with 4-imidazole derivatives. G. Galley, Patent Nr. 20070197622 (2007). (Reprosil 100 Chiral-NR, 8 μm)

 

Titanium(IV)-catalysed enantioselctive sulphenylation of β-Ketoesters. M. Jereb, Organic Letters, 7 (2005) 4041-4043. (ReproSil 100 Chiral-NR, 8 µm, 250 x 4.6 mm)

Reprosil Chiral-AM

 - Secretion of two novel enzymes, manganese 9S-lipoxygenase and epoxy alcohol synthase, by the rice pathogen Magnaporthe salvinii. A. Wennman, Journal of Lipid Research, 54 (2013) 762-775. (Reprosil Chiral-AM, 5 um, 250 x 2 mm)

 

- Catalytic Convergence of Manganese and Iron Lipoxygenases by Replacement of a Single Amino Acid. A. Wennman, The Journal of Biological Chemistry, 287 (2012) 31757-31765. (Reprosil 100 Chiral-NR, 8 μm, 250 x 2 mm;  Reprosil Chiral-AM, 5 μm, 250 x 2 mm) - Supplemental Data

 

- Idenification of putative residues involved in the accessibility of the substrate-binding site of lipogenase by site-directed mutagenesis studies. C. Palmieri-Thiers, Archives of Biochemistry  and Biophysics, 509 (2011) 82-89. (Reprosil Chiral-AM, 10 μm, 250 x 2 mm)

 

- LC-MS/MS analysis of epoxyalcohols and epoxides of arachidonic acid and their oxygenation by recombinant CYP4F8 and CYP4F22. T. Nilsson, Archives of Biochemistry and Biophysics, 494 (2010) 64-71. (Reprosil Chiral-AM, 5 µm, 250 x 2 mm;  Reprosil Chiral-NR, 8 µm, 250 x 4 mm)

- Peptides as catalysts for asymmetric 1,4-addition reactions of aldehydes to nitroolefins. M. Wiesner, Dissertation, Universität Basel, 2009. (Reprosil Chiral AM, 250 mm x 4.6 mm)

- Linoleate 9R-dioxygenase and allene oxide synthase activities of Aspergillus terreus. F. Jernerén, Archives of Biochemistry and Biophysics, on-line, DOI: 10.1016/j.abb.2009.12.022v (Reprosil Chiral-AM, 5 µm 250 x 2 mm und Reprosil Chiral-NR, 5 µm 250 x 2 mm)


- A lipoxygenase with dual positional specificity is expressed in olives (Olea europaea L.) during ripening.  C. Palmieri-Thiers, Biochimica et Biophysica acta, 1791 (2009) 339-346. (Reprosil Chiral-AM, 10 µm, 250 x 2 mm)

-
Leucine/valine residues direct oxygenation of linoleic acid by (10R)- and (8R)-dioxygenases. U. Garscha, Journal of Biological Chemistry, 284 (2009) 13755-13765. (Reprosil Chiral-AM, 10 µm, 250 x 2 mm;  ReproSil Chiral-NR, 8 µm, 250 x 2 mm)
Reprosil Chiral-AM-RP   

- 3D QSAR study, synthesis and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the Vesicular AcetylCholine Transporter (VAChT). M. Kovacs,
Bioorganic & Medicinal Chemistry, doi:10,1016/j.bmc.2010.08.028, (ReproSil Chiral AM-RP, 5 µm, 250 x 4.6 mm)


- Enantioseparation of vesamicol and novel vesamicol analogs by high-performance liquid chromatography on different chiral stationary phases. B. Wenzel, 1217 (2010) 3855-62. (Reprosil Chiral AM-RP, Chiral-OM, Chiral OM-RP, Chiral-AA, Chiral-NR)

Reprosil Chiral-OM

- In-depth characterization of six cellulose tris-(3,5-dimethylphenylcarbamate) in SFC. S. Khater, Poster, SFC-Symposium 2012. (Reprosil Chiral OM)   

- Enantioseparation of vesamicol and novel vesamicol analogs by high-performance liquid chromatography on different chiral stationary phases. B. Wenzel,
1217 (2010) 3855-62. (Reprosil Chiral-OM, Chiral OM-RP, Chiral AM-RP, Chiral-AA, Chiral-NR)

Reprosil Chiral-OM-RP
 

- Enantioseparation of vesamicol and novel vesamicol analogs by high-performance liquid chromatography on different chiral stationary phases. B. Wenzel, 1217 (2010) 3855-62. (Reprosil Chiral OM-RP, Chiral-OM, Chiral AM-RP, Chiral-AA, Chiral-NR)

Reprosil Chiral-CA

- Research review. A.J. Ram, Pharma Express, 16-31. March 2009. (ReproSil Chiral-CA, 5 µm, 250 x 2 mm)

- Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral drugs and their metabolites. S. Pérez, 27 (2008) 836-846. (Reprosil Chiral-CA)

- Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC–atmospheric pressure photoionization tandem mass spectrometry. J. Martens-Lobenhoffer, Journal of Chromatography B, 857 (2007) 301-307. (Reprosil Chiral-CA, 5 µm, 250 x 2 mm)
Reprosil Chiral-AA 

- Enantioseparation of vesamicol and novel vesamicol analogs by high-performance liquid chromatography on different chiral stationary phases. B. Wenzel, 1217 (2010) 3855-62. (Reprosil Chiral-AA, Chiral-OM, Chiral OM-RP, Chiral AM-RP, Chiral-NR)